Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|October 5, 2013
Theoretical considerations in using animal models of metastasis and brief methodology for in vivo colorectal cancer models in SCID and nude miceSue A Watson, Rajendra KumariCurrent Protocols|August 8, 2023
Humanized Mouse Models for Immuno-oncology Drug DiscoveryRajendra Kumari, Gerold Feuer, Ludovic BourréInternational Journal of Cancer|February 2, 2006
Nuclear targeting of a midregion PTHrP fragment is necessary for stimulating growth in breast cancer cellsRajendra Kumari, John F Robertson, Sue A WatsonCurrent Protocols|July 5, 2022
Translational and Clinical Relevance of PDX-Derived Organoid Models in Oncology Drug Discovery and DevelopmentRajendra Kumari, Xiaoxi Xu, Henry Qi-Xang LiBritish Journal of Pharmacology|November 5, 2003
ATP and UTP responses of cultured rat aortic smooth muscle cells revisited: dominance of P2Y2 receptorsRajendra Kumari, Gareth Goh, Leong L Ng, et al.The Journal of Biological Chemistry|September 21, 2012
Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancerKarl Deacon, David Onion, Rajendra Kumari, et al.Current Opinion in Pharmacology|October 7, 2021
Preclinical pharmacology modeling of chimeric antigen receptor T therapiesRajendra Kumari, Xuesong Ouyang, Jingjing Wang, et al.Molecular Cancer|January 15, 2011
Epigenetic reprogramming of breast cancer cells with oocyte extractsCinzia Allegrucci, Michael D Rushton, James E Dixon, et al.Plos One|May 20, 2024
An NGS-based assay for accurate detection and quantification of immune gene expression in mouse tumor modelsJia Xue, Xiaobo Chen, Xiaoyu An, et al.Stem Cell Research|November 25, 2010
Two new protocols to enhance the production and isolation of human induced pluripotent stem cell linesEmily Dick, Elena Matsa, Jayson Bispham, et al.Pageof 2